ELANCO ANIMAL HEALTH INC (ELAN) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:ELAN - US28414H1032 - Common Stock
23.43 USD
+0.34 (+1.47%)
23.45 USD
+0.02 (+0.09%)
ChartMill assigns a Buy % Consensus number of 82% to ELAN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 24.48. This target is 4.48% above the current price.
ELAN was analyzed by 21 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about ELAN.
In the previous month the buy percentage consensus was at a similar level.
ELAN was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-21 | Keybanc | Initiate | Overweight |
| 2025-11-06 | UBS | Maintains | Buy -> Buy |
| 2025-10-20 | UBS | Maintains | Buy -> Buy |
| 2025-10-07 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-09-24 | Stifel | Maintains | Buy -> Buy |
| 2025-08-11 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-08-08 | UBS | Maintains | Buy -> Buy |
| 2025-07-23 | UBS | Maintains | Buy -> Buy |
| 2025-07-17 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2025-07-02 | Stifel | Maintains | Buy -> Buy |
| 2025-06-26 | William Blair | Upgrade | Market Perform -> Outperform |
| 2025-05-19 | Stifel | Maintains | Buy -> Buy |
| 2025-05-08 | Stifel | Maintains | Buy -> Buy |
| 2025-04-14 | Stifel | Maintains | Buy -> Buy |
| 2025-03-06 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-02-26 | UBS | Maintains | Buy -> Buy |
| 2025-02-26 | Stifel | Maintains | Buy -> Buy |
| 2025-02-26 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-26 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-21 | Stifel | Maintains | Buy -> Buy |
| 2025-01-29 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-07 | Stifel | Maintains | Buy -> Buy |
| 2024-12-09 | UBS | Initiate | Buy |
| 2024-12-02 | Leerink Partners | Initiate | Market Perform |
| 2024-11-08 | Barclays | Maintains | Overweight -> Overweight |
| 2024-10-28 | Barclays | Maintains | Overweight -> Overweight |
| 2024-09-23 | Barclays | Maintains | Overweight -> Overweight |
| 2024-09-19 | Stifel | Reiterate | Buy -> Buy |
| 2024-09-19 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-07-01 | Piper Sandler | Maintains | Neutral -> Neutral |
ELANCO ANIMAL HEALTH INC / ELAN FAQ
What is the average price target for ELANCO ANIMAL HEALTH INC (ELAN) stock?
21 analysts have analysed ELAN and the average price target is 24.48 USD. This implies a price increase of 4.48% is expected in the next year compared to the current price of 23.43.
What is the consensus rating for ELAN stock?
The consensus rating for ELANCO ANIMAL HEALTH INC (ELAN) is 81.9048 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for ELAN stock?
The number of analysts covering ELANCO ANIMAL HEALTH INC (ELAN) is 21.